ISSN: 2332-0877

Jornal de doenças infecciosas e terapia

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

A look into Possible New Treatment Modality for COVID 19: ACE 2

Mayank Kapoor

Many articles about COVID 19 have mentioned various experimental drugs but nowhere it has been mentioned about any new research on ACE 2 (Angiotensin converting enzyme 2), which is a receptor for coronavirus, in the direction of curbing it. Hereby a logically deduced & scientific study backed analysis of a group of drugs affecting the ACE2 system is presented. ACE2 is an integral part of the pathogenic mechanisms & disease progression of COVID-19 & up regulation of ACE2 levels leads to significant reduction in morbidity & mortality of ARDS. SARSCoV- 2 binds to & down regulates this protective ACE2 & thus leads to the acute lung injury associated with it. Hence ACE 2 up regulation maybe the way to defeat this pandemic which has the whole of humanity in its grip.